Thermo Fisher Scientific's COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution

Thermo Fisher Scientific’s COVID-19 Response Continues to Expand with New High-Throughput Automated Testing Solution WALTHAM, Mass., Aug. 5, 2020 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today introduced a new highly automated, real-time PCR solution designed to analyze up to 6,000 samples in a single day to meet increasing... Read more

Brooks to Participate in the Needham Virtual SemiCap and EDA Investor Conference

CHELMSFORD, Mass., Aug. 4, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the Needham Virtual SemiCap and Electronic Design Automation Conference on Thursday, August 13, 2020 at 9:30 a.m. ET.  The 40-minute session will be webcast live via the Brooks investor relations website at www.brooks.investorroom.com/events. About Brooks AutomationBrooks... Read more

Brooks Automation Reports Results of its Third Quarter of Fiscal 2020, Ended June 30, 2020, and Announces Quarterly Cash Dividend

Brooks Automation Reports Results of its Third Quarter of Fiscal 2020, Ended June 30, 2020, and Announces Quarterly Cash Dividend Continued Revenue Growth and Earnings Expansion on Solid Execution Across Both Segments CHELMSFORD, Mass., July 30, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) today reported financial results for the third fiscal quarter, ended June... Read more

Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2

AUSTIN, Texas, July 22, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2 virus for high-throughput COVID-19 testing. The new test is a combination of the company’s original NxTAG RPP,... Read more

PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

Fully automated kit detects human antibodies of immunoglobulin class IgG to help identify individuals with adaptive immune response WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 21, 2020– PerkinElmer, Inc. (NYSE:PKI), a global leader committed to innovating for a healthier world, today announced the launch of a dry blood spot (DBS) based test for SARS-CoV-2 IgG using its GSP®/DELFIA® platform,... Read more

Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test

AUSTIN, Texas, July 20, 2020 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company’s xMAP® SARS-CoV-2 Multi-Antigen IgG Assay. Clinical laboratories can now use this serology assay to identify the presence of antibodies in people who have been infected with the... Read more

Brooks Automation Announces Third Quarter Fiscal 2020 Earnings Conference Call and Webcast

Brooks Automation Announces Third Quarter Fiscal 2020 Earnings Conference Call and Webcast CHELMSFORD, Mass., July 17, 2020 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2020 third quarter earnings which ended on June 30, 2020 on Thursday, July 30, 2020 after the market closes. The Company will host a conference call and live webcast... Read more

Promega Maxwell® RNA Extraction System Authorized for Use in CDC COVID-19 Emergency Use Authorization (EUA) Diagnostic Panel

Promega automated sample preparation solution added to CDC COVID-19 test protocol Madison, WI USA. (July 16, 2020) Promega Corporation Maxwell® RSC 48 Instrument and Maxwell® RSC Viral Total Nucleic Acid Purification Kit (Maxwell® Extraction System) are now in the Centers for Disease Control and Prevention’s (CDC) COVID-19 diagnostic protocol for emergency use. In a letter dated July... Read more

QIAGEN provides update on Q2 2020 results, announces strong outlook for Q3 and FY 2020, and 2021 perspectives in light of coronavirus pandemic

Venlo, The Netherlands, July 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced additional information on preliminary results for the second quarter and first half of 2020, along with an outlook for continued strong growth trends in the third and fourth quarters of 2020. QIAGEN also provided initial perspectives that business trends are expected... Read more

PerkinElmer Updates Second Quarter Outlook; To Hold Earnings Call on Tuesday, July 28, 2020

WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 13, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates growth in both reported revenue and organic revenue1 of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for PerkinElmer’s full-suite... Read more